<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05014906</url>
  </required_header>
  <id_info>
    <org_study_id>ROS001</org_study_id>
    <nct_id>NCT05014906</nct_id>
  </id_info>
  <brief_title>Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea</brief_title>
  <official_title>Efficacy of 45mg Oral Minocycline (Solodyn) and 45mg Oral Minocycline (Solodyn) Plus 15% Azelaic Acid (Finacea) in the Treatment of Acne Rosacea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dermatology Specialists Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dermatology Specialists Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rosacea is one of the most commonly occurring dermatoses treated by dermatologist today.&#xD;
      Rosacea is an inflammatory condition of the skin presenting as flushing and or blushing along&#xD;
      with redness, swelling, telangiectasia, and acne lesions. Minocycline has shown beneficial in&#xD;
      the treatment of inflammatory acne lesions in patients with rosacea. This study is to&#xD;
      evaluate the efficacy and tolerability of minocycline (Solodyn) alone versus minocycline&#xD;
      (Solodyn) in combination with azelaic acid 15%(Finacea) in the treatment of rosacea.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, randomized, outpatient, Investigator-blind study of minocycline 45 mg&#xD;
      and minocycline 45 mg plus 15% azelaic acid for the treatment of rosacea.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy analysis of the 12-week reduction in total lesion count</measure>
    <time_frame>12 weeks</time_frame>
    <description>The goal of analysis is to assess evidence of overall effect of 45mg minocycline and overall effect of 45 mg minocycline plus 15% azelaic acid in therapy of patients with acne rosacea.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy analysis of the12 week reduction in IGA (Investigators Global Assessment) per treatment group</measure>
    <time_frame>12 Weeks</time_frame>
    <description>Summary of the 12-week reduction in IGA for the full sample, by treatment group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy analysis of the 12-week reduction in CEA (Clinical Erythema Assessment) per treatment group</measure>
    <time_frame>12 Weeks</time_frame>
    <description>Summary of the 12 week reduction in CEA for the full sample, by treatment group</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Tolerability of treatment per group</measure>
    <time_frame>12 Week</time_frame>
    <description>Summary of adverse events suspected as related to study medication per treatment group</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Rosacea</condition>
  <arm_group>
    <arm_group_label>minocycline, azelaic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>minocycline vs minocycline in comination with 15% azelaic acid for treatment of rosacea</description>
  </arm_group>
  <arm_group>
    <arm_group_label>azelaic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>45 mg oral minocycline vs 45 mg oral minocycline plus 15% azelaic acid in the treatment of facial rosacea</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Minocycline 45 MG</intervention_name>
    <description>45 mg oral minocyclineonce daily vs 45mg oral minocycline once daily in combination with use of 15% azelaic acid</description>
    <arm_group_label>azelaic acid</arm_group_label>
    <arm_group_label>minocycline, azelaic acid</arm_group_label>
    <other_name>Solodyn</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Azelaic acid</intervention_name>
    <description>45 mg oral minocyclineonce daily vs 45mg oral minocycline once daily in combination with use of 15% azelaic acid</description>
    <arm_group_label>azelaic acid</arm_group_label>
    <arm_group_label>minocycline, azelaic acid</arm_group_label>
    <other_name>finacea</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18 or older with clinical diagnosis of rosacea&#xD;
&#xD;
          -  must have 10-40 facial inflammatory lesions and less than 2 nodules&#xD;
&#xD;
          -  women of child bearing potential must be non lactating&#xD;
&#xD;
          -  must have negative urine pregnancy test&#xD;
&#xD;
          -  must use effective form of birth control&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The use of systemic antibiotics within 30 days of study start&#xD;
&#xD;
          -  the use of topical medications within 14 - 30 days of study start depending on type of&#xD;
             topical medication&#xD;
&#xD;
          -  Patients with known sensitivity to tetracyclines&#xD;
&#xD;
          -  Patients who have had gastric bypass surgery or are considered achlorhydric&#xD;
&#xD;
          -  Patients taking drugs known as photosensitizers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James M Jackson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dermatology Specialists</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dermatology Specialists</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 22, 2013</study_first_submitted>
  <study_first_submitted_qc>August 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2021</study_first_posted>
  <last_update_submitted>August 13, 2021</last_update_submitted>
  <last_update_submitted_qc>August 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rosacea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rosacea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Minocycline</mesh_term>
    <mesh_term>Azelaic acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

